Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Centre Hospitalier Universitaire De Montpellier
Sponsor

Centre Hospitalier Universitaire De Montpellier

France 39 Avenue Charles Flahault, 34295 Montpellier, France

About the sponsor

Rheumatoid arthritis research includes treatment strategies for persistent inflammatory disease, with interest in biologic sequencing and disease control. Systemic sclerosis is also a focus, including severe, treatment-resistant forms associated with skin fibrosis and immune-mediated tissue damage.

  • Rheumatoid arthritis
  • Systemic sclerosis
  • Autoimmune disease

Work in this area reflects a strong interest in immune modulation, refractory disease, and outcomes linked to inflammatory activity.

About Specializations

Centre Hospitalier Universitaire De Montpellier runs clinical trials in conditions such as Hepatocellular carcinoma, Systemic scleroderma, Neurodevelopmental disorder, Relapsing-remitting multiple sclerosis, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

20 clinical trials

Systemic scleroderma

Recruiting

A Study Testing Anti-CD19 CAR T-Cell Therapy in Patients with Systemic Sclerosis Who Did Not Respond to Immunosuppressive Drugs

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Autologous T-Cells Transduced With Lentiviral Vector Expressing A Chimeric Antigen Receptor Directed Against Cd19
  • Sponsor:Centre Hospitalier Universitaire De Montpellier

Comparing Ursodeoxycholic Acid and Prednisone for Treating Liver Inflammation Caused by Cancer Immunotherapy in Adult Patients

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Centre Hospitalier Universitaire De Montpellier

Neurodevelopmental disorder

Recruiting

Study of levodopa and carbidopa treatment for patients with neurodevelopmental disorder caused by CTNNB1 gene mutation

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Carbidopa
  • Sponsor:Centre Hospitalier Universitaire De Montpellier

Relapsing-remitting multiple sclerosis

Recruiting

Study on Anti-CD20 Therapy and Drug Combination for Patients with Relapsing-Remitting Multiple Sclerosis

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dimethyl Fumarate
  • Sponsor:Centre Hospitalier Universitaire De Montpellier

Cholangiocarcinoma

Recruiting

Study of Gemcitabine and Oxaliplatin Infusion for Patients with Non-Metastatic Unresectable Intra-Hepatic Cholangiocarcinoma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Oxaliplatin
  • Sponsor:Centre Hospitalier Universitaire De Montpellier

Chronic obstructive pulmonary disease

Recruiting

Study of Azithromycin Treatment Based on Mucus Changes in Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Azithromycin Dihydrate
  • Sponsor:Centre Hospitalier Universitaire De Montpellier

Anaesthesia

Recruiting

Study on Dexmedetomidine and Sodium Chloride for Pain Management in Children Undergoing Surgery with Local Anesthesia

Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Dexmedetomidine
  • Sponsor:Centre Hospitalier Universitaire De Montpellier

Hepatocellular carcinoma

Recruiting

Study on Atezolizumab and Bevacizumab for Patients with Small Hepatocellular Carcinoma Undergoing Radiofrequency Ablation

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Centre Hospitalier Universitaire De Montpellier

Rheumatoid arthritis

Recruiting

Study on Abatacept for Rheumatoid Arthritis in Patients Responding to Initial TNF Inhibitor Treatment

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Centre Hospitalier Universitaire De Montpellier

General anaesthesia

Recruiting

Study on the Effects of Dexmedetomidine and Midazolam on Children's Experience After General Anesthesia

Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Midazolam
  • Sponsor:Centre Hospitalier Universitaire De Montpellier

Insomnia

Recruiting

Study of Daridorexant for Treating Insomnia in Patients with Mild Cognitive Impairment and Mild to Moderate Alzheimer's Disease

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Daridorexant
  • Sponsor:Centre Hospitalier Universitaire De Montpellier

Cardiac failure

Not yet recruiting

Effect of Acetazolamide Added to Standard Therapy on Weight Reduction and Symptom Relief in Patients with Heart Failure

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Acetazolamide
  • Sponsor:Centre Hospitalier Universitaire De Montpellier

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.